Your Web Site
German biopharmaceutical company GANYMED closes 65m round
Mainz, Germany-based biopharmaceutical company GANYMED Pharmaceuticals has closed a €65m financing round, led by Munich-based ATS Beteiligungsverwaltung and also including German investors Future Capital AG and MIG Verwaltungs...

